首页> 外文期刊>Endocrine journal >Comparison of Histological Findings and Parathyroid Scintigraphy in Hemodialysis Patients with Secondary Hyperparathyroid Glands
【24h】

Comparison of Histological Findings and Parathyroid Scintigraphy in Hemodialysis Patients with Secondary Hyperparathyroid Glands

机译:继发甲状旁腺功能亢进的血液透析患者的组织学检查结果和甲状旁腺闪烁显像的比较

获取原文
       

摘要

References(32) Cited-By(8) To determine the usefulness of parathyroid scintigraphy in histological estimation for secondary hyperparathyroidism (2HPT) using Tc-99m sestamibi or Tc-99m tetrofosmin. Tc-99m sestamibi (MIBI) and Tc-99m tetrofosmin (Tetro) parathyroid imaging following double-phase study, magnetic resonance imaging (MRI), and ultrasound were performed on 14 patients with 2HPT. All patients underwent parathyroidectomy. The uptake of two tracers in parathyroid areas was compared with the histopathologic findings. Forty-nine parathyroid glands were surgically explored and histologically proven to be hyperplastic. Of these, 42 were diagnosed with nodular type (N-type) hyperplasia, and 7 with diffuse type (D-type) hyperplasia. MIBI and Tetro parathyroid imagings detected 34 and 35 parathyroid glands, respectively. The sensitivity of MIBI was determined to be 76.2% (32/42) for N-type, and 28.6% (2/7) for D-type. The sensitivity of Tetro was determined to be 78.6% (33/42) for N-type and 28.6% (2/7) for D-type. The sensitivity of both MIBI and Tetro was significantly higher for N-type than for D-type, 76.2% (32/42) vs. 28.6% (2/7) in MIBI, P = 0.022; 78.6% (33/42) vs. 28.6% (2/7) in Tetro, P = 0.015. The sensitivity of MRI was determined to be 76.2% (32/42) for N-type and 42.9% (3/7) for D-type, and the sensitivity of ultrasound was 71.4% (30/42) for N-type and 71.4% (5/7) for D-type. There was no significant difference in the sensitivity of MRI or ultrasound between N-type and D-type. The uptake ratios of MIBI and Tetro were also greater for N-type than for D-type. The detectability of both MIBI and Tetro was greater for N-type than for D-type. Tc-99m MIBI or Tc-99m Tetro parathyroid scintigraphy therefore may be used clinically to distinguish N-type from D-type parathyroid gland hyperplasia.
机译:参考文献(32)被引用者(8)为了确定甲状旁腺闪烁显像在使用Tc-99m司他他比或Tc-99m trotrofosmin对继发性甲状旁腺功能亢进症(2HPT)的组织学评估中的有用性。对14例2HPT患者进行了双阶段研究后,进行了Tc-99m sestamibi(MIBI)和Tc-99m tetrofosmin(Tetro)甲状旁腺显像。所有患者均接受了甲状旁腺切除术。将甲状旁腺中两种示踪剂的摄取与组织病理学结果进行了比较。手术探查了49个甲状旁腺,并在组织学上证明是增生的。其中42例被诊断为结节型(N型)增生,7例被诊断为弥散型(D型)增生。 MIBI和Tetro甲状旁腺成像分别检测到34和35个甲状旁腺。对于N型,MIBI的灵敏度确定为76.2%(32/42),对于D型,MIBI的灵敏度为28.6%(2/7)。 Tetro的灵敏度被确定为N型为78.6%(33/42),D型为28.6%(2/7)。 N型的MIBI和Tetro的敏感性均显着高于D型,分别为76.2%(32/42)与MIBI中的28.6%(2/7),P = 0.022; 78.6%(33/42),而Tetro中为28.6%(2/7),P = 0.015。 MRI的灵敏度被确定为N型为76.2%(32/42),D型为42.9%(3/7),而超声对N型和高灵敏度为71.4%(30/42)。 D型为71.4%(5/7)。 N型和D型之间的MRI或超声敏感性没有明显差异。 N型的MIBI和Tetro的吸收率也比D型的大。 N型的MIBI和Tetro的检出率均高于D型。因此,Tc-99m MIBI或Tc-99m Tetro甲状旁腺闪烁显像可以在临床上用于区分N型和D型甲状旁腺增生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号